Literature DB >> 34110904

Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.

Joshua A Beckman1, Peter A Schneider2, Michael S Conte2.   

Abstract

Effective revascularization of the patient with peripheral artery disease is about more than the procedure. The approach to the patient with symptom-limiting intermittent claudication or limb-threatening ischemia begins with understanding the population at risk and variation in clinical presentation. The urgency of revascularization varies significantly by presentation; from patients with intermittent claudication who should undergo structured exercise rehabilitation before revascularization (if needed) to those with acute limb ischemia, a medical emergency, who require revascularization within hours. Recent years have seen the rapid development of new tools including wires, catheters, drug-eluting technology, specialized balloons, and biomimetic stents. Open surgical bypass remains an important option for those with advanced disease. The strategy and techniques employed vary by clinical presentation, lesion location, and lesion severity. There is limited level 1 evidence to guide practice, but factors that determine technical success and anatomic durability are largely understood and incorporated into decision-making. Following revascularization, medical therapy to reduce adverse limb outcomes and a surveillance plan should be put in place. There are many hurdles to overcome to improve the efficacy of lower extremity revascularization, such as restenosis, calcification, microvascular disease, silent embolization, and tools for perfusion assessment. This review highlights the current state of revascularization in peripheral artery disease with an eye toward technologies at the cusp, which may significantly impact current practice.

Entities:  

Keywords:  catheter; decision-making; intermittent claudication; peripheral arterial disease; risk factor

Mesh:

Year:  2021        PMID: 34110904     DOI: 10.1161/CIRCRESAHA.121.318261

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

Review 1.  Medial Arterial Calcification: A Significant and Independent Contributor of Peripheral Artery Disease.

Authors:  Cynthia St Hilaire
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-01-27       Impact factor: 8.311

2.  3D Printed Bioreactor Enabling the Pulsatile Culture of Native and Angioplastied Large Arteries.

Authors:  Rolando S Matos; Davide Maselli; John H McVey; Christian Heiss; Paola Campagnolo
Journal:  Front Cardiovasc Med       Date:  2022-06-21

Review 3.  Therapeutic angiogenesis-based strategy for peripheral artery disease.

Authors:  Jingxuan Han; Lailiu Luo; Olivia Marcelina; Vivi Kasim; Shourong Wu
Journal:  Theranostics       Date:  2022-06-27       Impact factor: 11.600

4.  Dual-Resonance (16/32 MHz) Piezoelectric Transducer With a Single Electrical Connection for Forward-Viewing Robotic Guidewire.

Authors:  Graham C Collins; Timothy A Brumfiel; Zachary L Bercu; Jaydev P Desai; Brooks D Lindsey
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2022-03-30       Impact factor: 3.267

5.  Peripheral Vascular Disease in 2021.

Authors:  Nicholas J Leeper; Naomi M Hamburg
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

6.  Changes to Drug-Coated Balloon Reimbursement Affect Peripheral Arterial Disease Patient Care: A Single-Center Experience.

Authors:  Arthur M Samia; George L Adams
Journal:  Cureus       Date:  2022-03-26

7.  Sourcing of human peripheral blood-derived myeloid angiogenic cells under xeno-free conditions for the treatment of critical limb ischemia.

Authors:  Christy Wing Tung Wong; Apurva Sawhney; Yalan Wu; Yi Wah Mak; Xiao Yu Tian; Hon Fai Chan; Anna Blocki
Journal:  Stem Cell Res Ther       Date:  2022-08-13       Impact factor: 8.079

8.  Resveratrol Promotes Angiogenesis in a FoxO1-Dependent Manner in Hind Limb Ischemia in Mice.

Authors:  Dongxiao Fan; Chenshu Liu; Zeling Guo; Kan Huang; Meixiu Peng; Na Li; Hengli Luo; Tengyao Wang; Zhipeng Cen; Weikang Cai; Lei Gu; Sifan Chen; Zilun Li
Journal:  Molecules       Date:  2021-12-12       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.